Immunic, Inc.
IMUX· Nasdaq
IMUXImmunic, Inc.
Filed Mar 31, 2025 · 10-K · 90 days after period end · 0001280776-25-000005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021 |
|---|---|---|---|---|
| Net Income | -$25.18M | -$21.57M | -$56.47M | -$21.19M |
| EPS Diluted | — | — | — | -$0.81 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR
ended Dec 31, 2024 · filed Mar 31, 2025 · 90 d after period end
